CURX vs DASH · $8.9M cap vs P/E 76, rev $8.49B
Curanex Pharmaceuticals Inc Common Stock (CURX) versus DoorDash, Inc. Class A Common Stock (DASH) — a side-by-side from cached financials, not a winner call.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
CURX does not have a complete income-statement cache yet.
Latest reported DASH revenue for 2026-06-30 was $8.49B. Net income was $384.0M. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
CURX currently screens at market cap $8.9M. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Not investment advice. Open the CURX and DASH stock pages for the full models.
Not investment advice.